HC Wainwright & Co. Reiterates Buy on Tyra Biosciences, Maintains $23 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Mitchell Kapoor has reiterated a Buy rating on Tyra Biosciences (NASDAQ:TYRA) with a maintained price target of $23.
May 10, 2024 | 11:41 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. reaffirms a Buy rating on Tyra Biosciences with a $23 price target, indicating a positive outlook on the stock.
The reiteration of a Buy rating and a specific price target by a reputable analyst firm like HC Wainwright & Co. typically signals a strong vote of confidence in the company's future performance. This endorsement can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100